Latest Insider Transactions at Recursion Pharmaceuticals, Inc. (RXRX)
This section provides a real-time view of insider transactions for Recursion Pharmaceuticals, Inc. (RXRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RECURSION PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RECURSION PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 03
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+3.66%
|
$62,500
$2.48 P/Share
|
Jan 03
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
10,000
-1.25%
|
-
|
Jan 03
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
10,000
+1.23%
|
-
|
Jan 02
2024
|
Dean Y Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,203
+0.09%
|
-
|
Jan 02
2024
|
Zavain Dar Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,393
+2.46%
|
-
|
Jan 02
2024
|
R. Martin Chavez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,900
+3.17%
|
-
|
Dec 28
2023
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
8,000
-1.89%
|
$80,000
$10.58 P/Share
|
Dec 28
2023
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+1.86%
|
$8,000
$1.06 P/Share
|
Dec 26
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
20,054
-0.27%
|
$200,540
$10.63 P/Share
|
Dec 15
2023
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
18,000
-11.63%
|
$162,000
$9.6 P/Share
|
Dec 15
2023
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+10.42%
|
$36,000
$2.22 P/Share
|
Dec 14
2023
|
Zavain Dar Director |
SELL
Open market or private sale
|
Direct |
20,141
-27.23%
|
$181,269
$9.0 P/Share
|
Dec 13
2023
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.55%
|
$175,000
$7.59 P/Share
|
Dec 13
2023
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+3.68%
|
$75,000
$2.22 P/Share
|
Dec 12
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.15%
|
$80,129
$7.4 P/Share
|
Dec 12
2023
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.58%
|
$175,000
$7.39 P/Share
|
Dec 12
2023
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+3.73%
|
$75,000
$2.22 P/Share
|
Dec 06
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
59,829
-7.03%
|
$418,803
$7.49 P/Share
|
Dec 06
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+3.54%
|
$62,500
$2.48 P/Share
|
Dec 06
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
10,000
-1.21%
|
-
|
Dec 06
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
10,000
+1.19%
|
-
|
Nov 28
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.15%
|
$68,682
$6.72 P/Share
|
Nov 16
2023
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
3,000
-0.72%
|
$18,000
$6.76 P/Share
|
Nov 16
2023
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+0.72%
|
$3,000
$1.06 P/Share
|
Nov 15
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,913
-2.02%
|
$118,391
$7.18 P/Share
|
Nov 15
2023
|
Shafique Virani Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,603
-2.57%
|
$25,221
$7.18 P/Share
|
Nov 15
2023
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
18,000
-11.37%
|
$108,000
$6.51 P/Share
|
Nov 15
2023
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+10.21%
|
$36,000
$2.22 P/Share
|
Nov 15
2023
|
Tina Marriott Larson President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,378
-1.28%
|
$37,646
$7.18 P/Share
|
Nov 15
2023
|
Michael Secora Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,172
-0.76%
|
$50,204
$7.18 P/Share
|
Nov 15
2023
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-1.3%
|
$175,000
$7.44 P/Share
|
Nov 15
2023
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+3.75%
|
$75,000
$2.22 P/Share
|
Nov 14
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$53,310
$6.32 P/Share
|
Nov 14
2023
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.63%
|
$150,000
$6.32 P/Share
|
Nov 14
2023
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+3.79%
|
$75,000
$2.22 P/Share
|
Nov 10
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
10,000
-1.18%
|
-
|
Nov 10
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
10,000
+1.17%
|
-
|
Nov 01
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-100.0%
|
$125,000
$5.13 P/Share
|
Nov 01
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
25,000
+50.0%
|
-
|
Nov 01
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
37,177
-4.25%
|
$185,885
$5.2 P/Share
|
Nov 01
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+3.45%
|
$62,500
$2.48 P/Share
|
Oct 31
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$44,425
$5.27 P/Share
|
Oct 26
2023
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
3,000
-0.71%
|
$15,000
$5.63 P/Share
|
Oct 26
2023
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+0.71%
|
$3,000
$1.06 P/Share
|
Oct 17
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$53,310
$6.58 P/Share
|
Oct 16
2023
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
18,000
-11.37%
|
$108,000
$6.3 P/Share
|
Oct 16
2023
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+10.21%
|
$36,000
$2.22 P/Share
|
Oct 16
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
10,000
-1.17%
|
-
|
Oct 16
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
10,000
+1.16%
|
-
|
Oct 11
2023
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.66%
|
$150,000
$6.85 P/Share
|